Today: August 28, 2015, 4:53 pm

Ireland Pharmaceuticals and Healthcare Market: New market analysis released
Ireland Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on 2014-04-02 21:46:03
Further negative developments have hit Ireland´s pharmaceutical industry hard in recent months, with exports of organic chemicals falling significantly in the wake of patent expirations. However, we believe that the worst is largely over, as the impact of patent expiries will ease of going into 2014. With the pace of austerity anticipated to remain unchanged, we expect to see uptake of generic drugs increase, and increasing costs being laid upon patients - such as the recent increase of prescription charges.

Headline Expenditure Projections:

- Pharmaceuticals: EUR2.17bn (US$2.75bn) in 2012 to EUR2.01bn (US$2.68bn) in 2013; -7.1% in local currency terms and -2.8% in US dollar terms. Forecast broadly in line with previous quarter.

- Healthcare: EUR14.95bn (US$17.99bn) in 2012 to EUR15.19bn (US$20.21bn) in 2013; +1.6% in local currency terms and +6.4% in US dollar terms. Forecast upwardly revised from previous quarter.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.